Selinexor (KPT-330)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Selinexor (KPT-330), covering 2025-06-04 to 2025-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]